市場調査レポート
商品コード
1469303
麻酔・呼吸・睡眠療法(ARS)機器の世界市場:規模、シェア、COVID-19の影響分析(2024年~2030年):MedSuiteAnesthesia, Respiratory & Sleep Therapy Devices Market Size, Share & COVID19 Impact Analysis | Global | 2024-2030 | MedSuite | Includes: Anesthesia Devices, Respiratory Devices & Sleep Management Devices |
麻酔・呼吸・睡眠療法(ARS)機器の世界市場:規模、シェア、COVID-19の影響分析(2024年~2030年):MedSuite |
出版日: 2024年04月08日
発行: iData Research Inc.
ページ情報: 英文 554 Pages
納期: 即日から翌営業日
|
世界の麻酔・呼吸・睡眠療法(ARS)機器の市場規模は2023年に109億米ドルとなりました。同市場は、予測期間中に4.5%CAGRで拡大し、148億米ドルに達すると予測されています。
世界のARS市場は、現在の人口動態を主な要因として大きな成長を遂げています。主な要因の1つは高齢化であり、これは世界のほとんどの地域でますます優勢になっています。この人口動態の変化は、加齢に伴う手術の増加、呼吸器疾患の増加、睡眠時無呼吸症候群の有病率の上昇につながります。さらに、特に北米、中東、オーストラリア、ニュージーランドなどの地域では、世界の肥満率の上昇が大きく寄与しています。肥満は呼吸器疾患や睡眠障害と密接に関連しており、体重関連の手術も増加しています。
2022年、世界のインフレ率は大幅に急上昇し、過去30年間で最高の上昇率を記録しました。このインフレ動向は、様々な産業で生産コストの上昇を招き、販売価格を押し上げました。ARS市場では、単純な機器に比べて複雑な機器のコスト上昇が顕著でした。このような値上げの影響は様々な分野に及んだが、消費者の受け入れ態勢が強化された結果、販売台数は維持され、市場の成長を後押ししています。今後、影響を受ける市場ではペースが緩やかになるもの、価格の上昇基調は続くと予想されます。
当レポートでは、世界の麻酔・呼吸・睡眠療法(ARS)機器市場について調査し、市場の概要とともに、セグメント別動向、COVID-19の影響分析、市場促進要因および阻害要因、競合市場シェア分析、および市場に参入する企業のプロファイルなどを提供しています。
List of Charts
List of Figures
The Global Anesthesia, Respiratory & Sleep Therapy (ARS) Market reached a value of $10.9 billion in 2023 and is projected to grow at a CAGR of 4.5% during the forecast period, reaching $14.8 billion.
The comprehensive report suite covering the global ARS market includes anesthesia delivery units, anesthesia monitors, anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen concentrators, therapeutic obstructive sleep apnea devices, and sleep diagnostics devices.
Unit Sales, Average Selling Prices, Market Value & Growth Trends
Forecasts Until 2030, and Historical Data to 2020
Market Drivers & Limiters for Each Segment
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
COVID19 Impact
Disease Overviews and Demographic Information
Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Anesthesia, Respiratory, and Sleep Therapy Market Insights
The global ARS market is experiencing significant growth, largely driven by current demographic trends. One of the key factors is the aging population, which is becoming increasingly predominant across most regions worldwide. This demographic shift leads to a rise in age-related surgeries, respiratory ailments, and a higher prevalence of sleep apnea cases. Additionally, the escalating obesity rates globally contribute significantly, particularly in regions like North America, the Middle East, Australia, and New Zealand. Obesity is closely linked to respiratory and sleep disorders, as well as an increase in weight-related surgeries.
In 2022, the global inflation rate saw a substantial surge, marking the highest increase in over 30 years. This inflationary trend led to heightened production costs across various industries, subsequently driving up selling prices. Within the ARS market, this translated into more pronounced cost hikes for complex devices compared to simpler ones. Despite these price increases affecting multiple sectors, consumers have shown greater acceptance, resulting in sustained unit sales and bolstering market growth. Moving forward, prices are anticipated to continue their upward trajectory, albeit at a slower pace in the affected markets.
Global Anesthesia, Respiratory, and Sleep Therapy Market Share Insights
In 2023, ResMed emerged as the frontrunner in the global anesthesia, respiratory, and sleep management device market, largely propelled by its substantial dominance in the therapeutic obstructive sleep apnea sector, which stands as the largest market within ARS. Moreover, ResMed's primary competitor, Philips, has grappled with product recalls in recent years, further widening ResMed's lead in the market. ResMed also maintains a presence in the ventilator and sleep diagnostics segments.
Despite experiencing a slight decline in share within the therapeutic obstructive sleep apnea market, Philips Healthcare has managed to retain its overall market position by excelling in the anesthesia monitor, ventilator, oxygen concentrator, and sleep diagnostics device markets. Philips holds the second-largest share in the total ARS market, significantly surpassing the third-leading company.
Teleflex holds the third-leading position in the total ARS market, mainly due to its dominant role in the disposables markets, leading both the anesthesia and respiratory disposables segments. With anticipated growth in these segments, Teleflex is poised to maintain its leadership position in the ARS market.
Market Segmentation Summary
Anesthesia Delivery Units Market - Segmented By:
Setting Type: Hospital (High-Complexity, Low-Complexity), ASC
Anesthesia Monitors Market
Anesthesia Disposables Market - Segmented By:
Device Type: Anesthesia Circuit, Anesthesia Mask, Endotracheal Tube, Laryngeal Mask (Disposable, Reusable)
Ventilator Market - Segmented By:
Device Type: Acute Care, Sub-Acute Care, Home Care, Neonatal, Non-Invasive
Nebulizer Market - Segmented By:
Device Type: Compressor/Jet Nebulizer (Stationary, Portable), Ultrasonic Nebulizer, Vibrating Mesh Nebulizer
Respiratory Disposable Devices Market - Segmented By:
Device Type: Oxygen Cannula, Oxygen Mask, Tracheostomy Tube, Resuscitator, Heat and Moisture Exchanger (HME/HMEF)
Oxygen Therapy Devices Market - Segmented By:
Device Type: Oxygen Concentrator (Stationary, Portable)
Therapeutic Obstructive Sleep Apnea Devices Market - Segmented By:
Device Type: Positive Airway Pressure (Continuous, Auto-Titrating, Bi-Level), Sleep Therapy Interface (Nasal Mask, Full-Face Mask, Nasal Pillow/Alternative Interface)
Sleep Diagnostic Devices Market - Segmented By:
Device Type: Polysomnography, Home Respiratory Polygraphy
Research Scope Summary
Regions: North America(Canada, United States), Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela), Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine), Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Mongolia, Malaysia, Myanmar, New Zealand, Philippines, Pakistan, Singapore, South Korea, Taiwan, Thailand, Uzbekistan, Vietnam), Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2023
Forecast: 2024-2030
Historical Data: 2020-2023
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.
TABLE of CONTENTS
TABLE of CONTENTSi
List of Figuresxii
List of Chartsxxix
executive summary1
Global Anesthesia, Respiratory and Sleep Management Device Market Overview1
Competitive Analysis4
Market Trends8
Market Developments10
Markets Included13
Regions Included15
Version History17
research methodology18
impact of covid-19 on THE global Anesthesia, Respiratory, and Sleep Management Market32
Disease Overview44
Product Assessment48
Global Anesthesia, Respiratory and Sleep Management Device Market Overview137
Anesthesia Delivery Unit Market187
Anesthesia Monitor Market225
Anesthesia Disposables Market243
Ventilator Market294
Nebulizer Market346
Respiratory Disposables Market397
Oxygen Concentrator Market442
Therapeutic Obstructive Sleep Apnea Device Market476
Sleep Diagnostics Device Market533
Abbreviations566